Pacton Gold Appoints Sprott Capital Partners as Advisor
Momentum Public Relations
Press Release: March 15 2018
Pacton Gold Inc. (TSXV: PAC) (the ” Company ” or ” Pacton “) is pleased to announce the appointment of Sprott Capital Partners as advisors to assist the Company with its awareness and marketing arrangements, including providing strategic capital advice to the Company.
About Sprott Capital Partners
Sprott Capital Partners , a division of Sprott Private Wealth LP, was formed in 2016 to provide advice and capital raising services to natural resources companies. Led by a team of seasoned investment banking professionals with extensive networks of industry contacts, Sprott Capital Partners provides expert counsel to its clients. Sprott Captial Partners was involved in one billion dollars of capital raising in 2017.
On Behalf of the Board of Pacton Gold Inc.
Alec Pismiris
Interim President & CEO
For more information, please contact 1-(855)-584-0258 or dom@pactongold.com.
- Published in Pacton Gold Inc.
Alliance Mining Now Drilling Packsack Gold Property, Bissett Gold Camp, Manitoba
Momentum Public Relations
Press Release: March 15 2018
Alliance Mining Corp. (TSX-v: ALM) (“Alliance” or the “Company”) has commenced drilling on its Packsack gold property located in Manitoba’s Bissett gold camp. The Packsack property forms part of the company’s Red Rice Lake gold project. Wynne Mining Services has been contracted to undertake the drill program which will be supervised by Alliance’s consulting geologist William C. Hood P. Geo. The approximately 1,000 metre drill program will consist of at least three holes, two of which will target an area under the known mineralization plus a shorter hole to target the upper part of the big Dome Vein in order to confirm the grade/width of the known mineralization. This is the first significant drill program to test under the 500 ft (152 m) level exploration drift on the Packsack property.
To view the graphic in its original size, please click here
The Packsack property hosts several gold-bearing veins within a conjugate fracture set adjacent to the Red Rice shear zone. Previous exploration on the Packsack property has been focused on the Big Dome Vein, with a shaft to 525 ft (160 m) and 2867 ft (874 m) of drifting and crosscutting on 4 levels down to 500 ft (152 m), all completed between 1936 and 1940. The structural control on veining at the Packsack property is similar to that at the True North Mine, 4 km northeast, operated by Klondex Mines Ltd.
To view the graphic in its original size, please click here
Alliance Mining has an option to acquire 100 per cent of the Red Rice Lake property located in the centre of the Bissett gold camp in Manitoba. The property is located close to the town of Bissett, Man., and just four kilometres south from Klondex Mines’ True North gold mine. The Red Rice Lake gold property claims are located within the Archean Rice Lake greenstone belt in southeastern Manitoba. This belt forms part of the Uchi sub province that includes the Red Lake and Pickle Lake belts in Northwestern Ontario.
Alliance is actively seeking to expand its presence in the Bissett Gold camp through future property acquisitions and/or potential joint venture exploration partnerships with neighbouring companies. Please call us directly.
William C. Hood, P.Geo, a qualified person as defined by National Instrument 43-101, is responsible for the technical information contained in this news release.
To see the official and full News Release with images visit www.AllianceMining.com
ON BEHALF OF THE BOARD
Christopher R. Anderson
President, CEO and Director
FOR FURTHER INFORMATION PLEASE CONTACT:
Alliance Mining Corp.
(604) 488-3900
Investor Relations:
Antony Claydon: 604-445-5421
E-mail: ir@alliancemining.com
This press release includes certain statements that may be deemed “forward-looking statements”. All statements in this release, other than statements of historical facts, that address future exploration drilling, exploration activities and events or developments that the Company expects, are forward looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include exploitation and exploration successes, continued availability of financing, and general economic, market or business conditions.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Alliance Mining Corp.
888 Dunsmuir Street – Suite 888,
Vancouver, B.C., V6C 3K4
To view the original release (with media), please click here
- Published in Alliance Mining
Arctic Star Discovers New Kimberlites at the Timantti Project in Finland, the Vasa Swarm
Momentum Public Relations
Press Release: March 15 2018
Arctic Star Exploration Corp (TSXV: ADD) (OTCQB: ASDZF) (FSE: 82A1) (WKN: A2DFY5) (“Arctic” or the “Company”) is pleased to announce that another new kimberlite grouping has been discovered on its 100% owned Timantti Diamond Project in Finland (the “Project”). This discovery was made when the excavator, pit-sampling the basal till in the northern part of the 243 Ha Exploration Permit, exposed two bifurcating kimberlite dykes approximately 2.2 kilometres north of the Wolf kimberlites.
The discovery, being referred to as the Vasa kimberlite dyke swarm, was made in two pits 10 metres apart. The first pit revealed a single 1.2 metre wide kimberlite dyke, while the second pit exposed two bifurcating dykes, of similar width. These dykes, with one striking almost east-west and the second striking approximately north-south appear to merge into one another in the pits. The kimberlites look very similar to the mica-rich and olivine-bearing variety present at the Wolf kimberlite discoveries 2.2 kilometres to the South.
The kimberlite in the Vasa pits is the intensively weathered variety known as yellow ground, similar to the Wolves. The presence of a full suite of kimberlitic indicator minerals, demonstrating deep lithosphere sampling, has been confirmed by the GTK (Finnish Geological Survey) although these minerals have not yet been chemically analyzed.
Buddy Doyle, VP Exploration stated, “This is the first kimberlite discovery away from the Wolf area and as such represents a totally new system and provides further proof that here at Timantti, we are dealing with a kimberlite field. We suspect that, based on public information, the field is measured in tens of kilometers in extent. It is known that an extensive kimberlite indicator mineral plume occurs in the till along the Russian border, 30 kilometers to the East. The kimberlites discovered thus far in the area, cannot explain the extent of this plume.”
The drill rig was dispatched to this area and has completed four angled reconnaissance holes on a 40-metre-long north-south traverse for a total of 160 metres of drilling. The holes were inclined at 45 degrees. Two separate kimberlite dykes were intercepted by the drilling, varying in width from 0.9 to 1.6 metres. Again, kimberlitic Indicator minerals from the deep lithosphere, were present in the drill core.
The following table summarizes the essential data on drill holes for this release:
Hole No. | Easting (m) |
Northing (m) |
Bearing/Dip (degrees) |
Total Depth |
From (m) |
To (m) |
Width (m) |
Description |
VS-002 | 4472300 | 7337440 | 180/45 | 60.4 | 31.1 | 32.0 | 0.9 | Kimberlite |
VS-003 | 4472298 | 7337421 | 150/45 | 41.3 | 18.9 | 20.1 | 1.2 | Kimberlite |
VS-004 | 4472298 | 7337421 | 165/45 | 40.1 | 17.0 | 18.9 | 1.9 | Kimberlite |
Notes: Co-ordinates use the KKJ system. Core diameter: 36mm, maximum true widths will be approximately 70% of the drill intercepts reported if the dykes are vertical. The Country Rock consisted of quartzites, schists and greenstones, the till cover was 4-5m thick downhole in each hole. Drill hole VS-001 did not intersect kimberlite.
The intercept in drill hole VS-002 appears to be a separate dyke to those exposed in the pits, the intercepts in VS-003 and VS-004, are thought to be the same east-west dyke as in the pits. Therefore, with the merging dyke exposed in the second pit there have been three separate dykes identified thus far, in this swarm.
Approximately 32 kg of kimberlite material from the pits is being sent for caustic fusion and indicator mineral analysis. Similarly, the kimberlite core will be split and sent for the same analyses. Detailed petrology and age dating will also be conducted on all relevant discoveries to gain a deeper understanding of this newly recognized kimberlite group.
The current focus is on the 243 Ha Exploration Permit area however this will expand to cover the adjacent and surrounding 95,700 Ha Exploration Reservation in the near future. Here the Company anticipates using airborne geophysics and more regional till sampling to potentially discover more kimberlites over the larger land package. This regional work will be followed up by drill testing of priority rated anomalies.
The drill rig is now testing the Grey Wolf discovery (see news release February 20, 2018) and the details of the kimberlite intercepts here will be the subject of a future news release. After testing the Grey Wolf kimberlite, the drill will move to the White and Black Wolves to collect a large caustic fusion sample to better understand the grade and size of these diamondiferous bodies.
The Qualified Person for this news release is Roy Spencer, Fellow AUSIMM, a Geologist of over thirty years’ experience in diamonds.
About Arctic Star
The Company owns 100% of the recently acquired Timantti Diamond Project including a 243 Ha Exploration Permit and a 95,700 Ha Exploration Reservation near the town of Kuusamo, in Finland. The project is located approximately 550km SW of the operating Grib Diamond Mine in Russia. Arctic has commenced its exploration in Finland on the Timantti Project, where four diamondiferous kimberlite bodies may represent the first finds in a large kimberlite field. The Company also controls diamond exploration properties in Nunavut (Stein), the NWT (Diagras and Redemption) and a rare metals project in BC (Cap).
Arctic Star has a highly experienced diamond exploration team previously responsible for several world class diamond discoveries.
ON BEHALF OF THE BOARD OF DIRECTORS OF ARCTIC STAR EXPLORATION CORP.
Scott Eldridge, President & CEO
+1 (604) 722-5381
scott@arcticstar.ca
Patrick Power, Executive Chairman
+1 (604) 218-8772
- Published in Arctic Star Exploration
Crystal Lake to start drilling at Nicobat
Momentum Public Relations
Press Release: March 15 2018
Crystal Lake Mining Corp.(CLM:V) has provided an update on its 100-per-cent-owned Nicobat project, where the company is developing a pipeline of highly prospective nickel sulphide targets. Recently expanded to cover 50 square kilometres in Northwestern Ontario’s Rainy River district, Nicobat features excellent infrastructure (road, rail and power access) and a historic nickel-copper-cobalt sulphide mineral zone defined by drilling more than four decades ago.
Highlights:
- Crews are mobilizing to commence drilling within the next seven days at Nico 1 on the western contact of the Dobie Intrusion (below and north of the historic zone);
- Lamontagne Geophysics Ltd. has been contracted to carry out surface and then borehole electromagnetic surveys upon completion of diamond drill holes at Nico;
- A deep penetrating EM survey will be flown by CGG Canada Services Ltd. over Crystal Lake’s claims including the Nico 1 and Nico 2 properties. The objective of the survey is to detect an electrically conductive signature of sulphide mineralization associated with mafic intrusive bodies and strong magnetic anomalies that may represent mafic-ultramafic intrusions under cover.
Crystal Lake Mining has assembled a proven geological and geophysical team to unlock the full potential of its Nicobat project which is being targeted for high-grade nickel, copper, cobalt and precious metal mineralization.
The Rainy River district is situated between major translithospheric faults, and the mafic-ultramafic intrusions in this region are prospective for magmatic sulphide mineralization.
The Nicobat project is near Emo, Ont., approximately 35 kilometres east of the Rainy River gold mine.
New website
Crystal Lake Mining invites investors to check out the company’s new website.
Qualified person
The technical information in this news release has been reviewed and approved by Dr. Peter C. Lightfoot, PGeo, and Dr. Elisabeth Ronacher, who are both qualified persons responsible for the scientific and technical information in this news release under National Instrument 43-101 standards. Certain technical information in this news release has previously been disclosed by Crystal Lake Mining in its public disclosure record. Readers should refer to Crystal Lake Mining’s full public disclosure record on SEDAR.
About Crystal Lake Mining Corp.
Crystal Lake Mining is a Canadian-based junior exploration company focused on building shareholder value through new nickel-rich sulphide discoveries in the underexplored Rainy River district of Northern Ontario using technical excellence in exploration target development and technologies.
We seek Safe Harbor.
- Published in Crystal Lake Mining
DIAGNOS Announces the Opening of a Screening Clinic at Chaparral’s Health Management Wellness Center for Medicare Beneficiaries
Momentum Public Relations
Press Release: March 14 2018
Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture:ADK) (OTCQB:DGNOF) a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the opening of a third eye screening clinic in California located at Chaparral Medical Group Health Management Wellness Center.
In 2010, Medicare launched an annual benefit to all their members at Chaparral’s Health Management Wellness Center. The goal is to help promote preventive care methods, emphasizing on how to prevent disease instead of treating disease. With that, Chaparral Medical Group has decided it will automatically include eye screening using our CARA platform for diabetic and pre-diabetic patient at their annual visit.
“Chaparral is introducing AI to enhance the overall value of the annual health examination to Medicare members by encompassing CARA as an additional screening test for the annual wellness program. It is estimated that Medicare currently has 44 million beneficiaries enrolled in the Medicare program, some 15 percent of U.S. population. Having Chaparral Medical Group as a trusted partner will help to deploy faster while meeting all the industry requirements,” said Yves-Stephane Couture, VP sales at DIAGNOS.
“By adding eye screening with retina anomalies detection, we are broadening our study for annual wellness visits. As DIAGNOS continues to develop new algorithms and detect more illness, it will significantly help us to prevent disease evolution and take early action. We are proud to use DIAGNOS’ state of the art technology and to benefit from the Artificial Intelligence in our daily fight against diseases and we look forward to using them at the Health Management Centre,” said Dr. Jeereddi Prasad MD, Diabetes Specialist, President, and Medical Director of Chaparral Medical Group.
About Chaparral Medical Group
Chaparral Medical Group is a 80 physicians multi-specialty group serving the communities of Claremont, La Verne, San Dimas, Fontana, Pomona, Rancho Cucamonga, Upland, Chino Hills and Diamond Bar in Southern California. Over 20 primary care physicians serve as the group’s clinical core, and work together with their medical and surgical specialists to provide outstanding care to the patient population Southern California. They have been serving the community since 1978 and their unwavering commitment to patient care and physician work satisfaction are what have driven them to become the most trusted and relied-upon group of physicians in their area.
About CARA
CARA is a tele-ophthalmology platform that integrates with existing equipment (hardware and software) and processes at the point of care (POC) and comprises: image upload, image enhancement automated pre-screening, grading by a specialist, and referral to a specialist. CARA’s Artificial Intelligence, based on our FLAIRE technology, image enhancement algorithms make standard retinal images sharper, clearer, and easier to read. CARA is accessible securely over the internet, and is compatible with all recognized image formats and brands of fundus cameras, and is EMR compatible. CARA is a cost-effective tool for screening large numbers of patients, in real time and has been approved by regulatory authorities including Health Canada, US Food and Drug Administration, the European Union and others.
Additional information is available at www.diagnos.ca and www.sedar.com.
For further information, please contact:
Mr. André Larente, President | Daniel Renaud or Thomas Renaud, Managing Directors |
DIAGNOS Inc. | Arrowhead Business and Investment Decisions, LLC |
Tel: 450-678-8882 ext. 224 | Tel: +1 212 619 6889, ext. 7010 |
alarente@diagnos.ca | diagnos@arrowheadbid.com |
This news release contains forward-looking information. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in these statements. DIAGNOS disclaims any intention or obligation to publicly update or revise any forward-looking information, whether as a result of new information, future events or otherwise. The forward-looking information contained in this news release is expressly qualified by this cautionary statement.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
- Published in Diagnos
Tetra Bio-Pharma Announces FDA Orphan Drug Designation for PPP001 in Treatment of Complex Regional Pain Syndrome
Momentum Public Relations
Press Release: March 14 2018
Tetra Bio-Pharma Inc. (“Tetra” or the “Corporation”) (TSX VENTURE:TBP)(OTCQB:TBPMF), today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the active ingredients of its PPP001 drug (delta-9-tetrahydrocannabinol 9.5% and cannabidiol 2.5%) for the treatment of complex regional pain syndrome (CRPS). The Orphan Drug Designation was granted for the active moiety of the drug PPP001 and not the formulation.
The FDA Orphan Drug Designation program provides orphan status to drugs intended to treat rare diseases or disorders that affect less than 200,000 people in the USA. This designation gives Tetra a seven-year marketing exclusivity, after drug approval by the FDA, and provides Tetra potential incentives such as access to federal grants and tax credits as well as a waiver of Prescription Drug User Fee Act filing fees.
Tetra successfully completed a placebo-controlled Phase 1a and 1b study of PPP001 in healthy volunteers and demonstrated that PPP001 can be safely consumed. “We are pleased to receive FDA Orphan Drug Designation for PPP001 and we look forward to discussing the clinical program with the US FDA that will be used to demonstrate the safety and efficacy in patients suffering from CRPS,” said Guy Chamberland, M.Sc., Ph.D., Chief Scientific Officer of Tetra.
According to the USA National Institute of Health, “complex regional pain syndrome (CRPS) is a chronic pain condition that most often affects one limb (arm, leg, hand, or foot) usually after an injury. CRPS is believed to be caused by damage to, or malfunction of, the peripheral and central nervous systems. CRPS is characterized by prolonged or excessive pain and changes in skin color, temperature, and/or swelling in the affected area.”
Appointment of a New Director – Tetra also announced the appointment of a new Director, Mr. Benoit Chotard, effective immediately. Mr. Chotard was previously a member of the Board of Directors from September 2016 to July 2017, he left for personal reasons, no longer applicable, and is pleased to come back. “We are glad to welcome back Mr. Chotard to the board and we look forward to working closely with him in building Tetra as a leading biopharmaceutical organization,” said Andre Rancourt, Chairman of Tetra Bio-Pharma. “Mr. Chotard’s tremendous experience as an advisor of publicly listed companies will be a huge addition to our team. His local and international network will be a key factor in the Company’s growth.”
Benoit Chotard is a corporate finance & development executive who has over 20 years of international corporate finance, management and public market expertise. Previously, Mr. Chotard was employed as managing partner at Capital Force United, as President & CEO, and Director of Orletto Capital Inc., Vice-president Corporate Development for Pakit Inc., Senior Vice-president Finance Corporate Development and acting as Chief Financial Officer for CANTRONIC Systems (Canada) Inc., Vice-President Chief Financial Officer of Victhom Human Bionics, and spent eight years as Head of the Technology Investment Group of National Bank Financial Inc.
Mr. Chotard has been a Member of “Ordre des ingénieurs du Québec” since 1989 and obtained a bachelor’s degree in Chemical Engineering (1989) and a MBA (1993) from the Université de Sherbrooke.
About PPP001:
PPP001 aims to be the first smokable marihuana for advanced cancer pain under prescription. It is a dried cannabis pellet designed to be smoked in an inhalation device specifically developed for this product. PPP001 is a unique blend of 3 strains of standardized dried cannabis, creating a drug substance with 9.5% THC and 2.5% CBD.
About Tetra Bio-Pharma:
Tetra Bio-Pharma (TSX VENTURE:TBP)(OTCQB:TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and clinical development. Tetra is focusing on three core business pillars: clinical research, pharmaceutical promotion and retail commercialization of cannabinoid-based products.
More information at: www.tetrabiopharma.com
Source: Tetra Bio-Pharma
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-looking statements
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Corporation believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Corporation’s ability to control or predict, that may cause the actual results of the Corporation to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the failure to obtain sufficient financing to execute the Corporation’s business plan; the success of the Rx Princeps™product offering and inhalation device; guidance on expected sales volumes associated with the Rx Princeps™product offering and inhalation device; competition; regulation and anticipated and unanticipated costs and delays, and other risks disclosed in the Corporation’s public disclosure record on file with the relevant securities regulatory authorities. Although the Corporation has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Corporation does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
Tetra Bio-Pharma Inc.
Dr. Anne-Sophie Courtois, DVM
Vice President, Marketing & Communications
(438) 899-7575
For media information, please contact:
Daniel Granger
Daniel.granger@acjcommunication.com
ACJ Communication
O: 1 514 840 7990 / M: 1 514 232 1556
For investors information, please contact:
investors@tetrabiopharma.com
(438) 504-5784
- Published in Tetra Bio Pharma
Auxico Announces Discovery of Scandium and Gold on the Metalor Property, Colombia
Momentum Public Relations
Press Release: March 13 2018
Auxico Resources Canada Inc. (CSE:AUAG) is pleased to announce the sampling results taken from the Metalor property in Colombia. A total of six selected samples were taken. Five of the six samples contain scandium within an average content of 1,300 grams of scandium per tonne. Five of the six samples contain gold with an average gold content of 21 g/t.Scandium oxide currently sells at $4,200 US per kilogram and scandium metal sells at $15,000 US per kilogram. The selected samples were taken over a distance of approximately 481m. This fault can now be observed over a width of at least 480m on the property and the high-grade scandium and gold values are associated with the fault, which is represented by an exhalative shale sequence containing disseminated to massive sulphide strata. On February 16th, 2018, the Trump administration declared scandium as a strategic metal (“Critical Minerals”) for the United States, to be considered “vital for the Nation’s security and economic prosperity”.
Sample | Analysis / XRF mode |
Sc (ppm) (g/t) |
Au (ppm) (g/t) |
M1 | 1 | / | 30.60 |
2 | 1,315.01 | / | |
3 | 1,808.43 | 1.75 | |
M2 | 1 | 1,695.39 | / |
2 | 2,025.01 | 1.61 | |
3 | 2,461.35 | / | |
M3 | 1 | / | 36.14 |
2 | 237.46 | 40.08 | |
3 | / | 36.84 | |
M4 | 1 | 167.01 | / |
2 | 1,132.13 | / | |
3 | 4,627.06 | 4.10 | |
M5 | 1 | / | 21.51 |
2 | / | 10.03 | |
3 | / | 33.18 | |
M6 | 1 | 234.53 | / |
2 | 246.70 | / | |
3 | 580.05 | / |
Table 1: Recoveries of scandium and gold from the Metalor Property
All of the samples were taken by Jesus Eduardo Pimienta González, independent consulting mining engineer. They were tagged, located using a handheld Garmin GPS unit, put into separate sample bags, and brought into the Symtek laboratory in Bogota. The samples are characterized by a combination of river floats, subcrop at the base of the mountains adjacent to the river, and also outcrop, and are not necessarily representative of the mineralization throughout the property, however, Auxico is planning a reconnaissance prospecting and sampling campaign which will begin shortly. This campaign will include detailed exploration work in the area of the fault where these samples were collected.
The samples were analyzed in Bogota, Colombia by Symtek, an SGS affiliate, using a Thermo Scientific Niton XL5 handleld XRF Analyzer, a mass spectrometer which measures 68 elements including gold and scandium in parts per million (ppm) with a 99.7% confidence interval. The samples were tested in the lab in three different modes as shown on the table above i.e. (1) rare earth mode, (2) soil mode and (3) geological mode. These same samples were just sent to SGS laboratory in Medellin for sample preparation and will be analyzed for gold by fire assay with a gravimetric finish, and will also be analyzed using sodium peroxide fusion with an ICP-AES finish on 29 elements including Scandium. Results of the selected samples will be disclosed as soon as they become available from SGS.
Qualified Person
This news release was reviewed and approved by Joel Scodnick, P.Geo., an independent consultant to Auxico, in his capacity as a Qualified Person, as defined by National Instrument 43-101.
ON BEHALF OF THE BOARD OF DIRECTORS
« signed »
Mark Billings
President, Auxico Resources Canada Inc.
mb@auxicoresources.com
Cell: +1 514 296 1641
About Auxico Resources Canada Inc.
Auxico Resources Canada Inc. (“Auxico”) in a Canadian company that was founded in 2014 and based in Montreal. Auxico is engaged in the acquisition, exploration and development of mineral properties in Mexico. The Company has a 100% interest in the Zamora Silver-Gold Property in Sinaloa, Mexico. Auxico will continue to identify and potentially acquire additional property interests and conduct exploration and evaluation of these properties to assess their potential.
- Published in Auxico Resources
Relevium Announces Initial Launch of Hempco’s PlanetHemp® in the USA
Momentum Public Relations
Press Release: March 13 2018
Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (“Relevium”) and Hempco Food and Fiber Inc (TSX VENTURE:HEMP) (‘Hempco’) are pleased to announce the launch of five PlanetHemp® products in the U.S., which are expected to be live the week of March 19, 2018.
Highlights
- Initial launch of five (5) products under the PlanetHemp® brand
- Subsequent additions to the PlanetHemp® product offering in planning stages
- Relevium will launch a Bioganix® Hemp-based Vegan Omega Essential Fatty Acids
Aurelio Useche, CEO of Relevium stated: “Increasing market awareness of the beneficial properties of hemp are creating strong momentum in the food and food additives space. Through our exclusive partnership with Hempco, giving us access to its PlanetHemp® brand, we are exceptionally well positioned to gain market share in this rapidly growing segment of the market. The launch of these products in the United States via Amazon, and in the future on other main sites, such as Jet.com, is an important milestone for both companies. We anticipate this will drive considerable growth and create significant shareholder value for both companies.”
Diane Jang, CEO of Hempco Canada stated: “We are pleased with Relevium’s initiatives towards the launch of the PlanetHemp® products in the U.S. Market. This relationship adds a significant presence on the most important eCommerce channels in the U.S. and we look forward to building a successful long-term and expanding relationship with Relevium.”
The initial launch will comprise of five (5) products, including PlanetHemp® Protein Superfoods and Hemp Seeds.
Relevium will also be launching a Hemp-based Vegan Omega Essential Fatty Acids under its Bioganix® brand.
About Hemp and Derivatives
Hemp is a distinct variety of the Cannabis Sativa plant that is grown specifically for its derived products and applications. Hemp has gained considerable popularity because of its health and wellness effects on humans and pets, primarily due to its well-balanced nutritional value, alkalinity and the presence of cannabidiol, a compound known to promote and support overall health.
According to a recent article published by Forbes, hemp-derived cannabidiol (CBD) is projected to be a billion-dollar market in just three years, according to a new report by Brightfield Group. The data company estimates that hemp CBD sales have already hit $170 million in 2016 and a 55% compound annual growth rate over the next five years will cause the market to crack the billion-dollar mark.
About Hempco
For more than 12 years Hempco has been a trusted and respected pioneer, innovator and provider of premier hemp seed foods. Hempco is committed to developing hemp foods, hemp fiber and hemp nutraceuticals, a “tri-crop” opportunity for producers and processors. Hempco is expanding its processing ability to meet global demands in a 56,000sq. ft. facility located at Nisku, Alberta. Hempco’s common shares trade on the TSX Venture Exchange under the symbol “HEMP”.
About Relevium Technologies
Relevium is a TSXV-listed company focused on growth through the acquisition of businesses, products and/or technologies with a focus on e-commerce in the growing health and wellness sector. Relevium Technologies Inc. also holds patented intellectual property for the use of static magnetic fields for application on wearable devices.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Note Regarding Forward-Looking Statements
This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, assumptions or expectations of future performance, including the timing and completion of the proposed acquisitions, are forward-looking statements and contain forward-looking information. Generally, forward- looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including the assumptions that the Company will obtain stock exchange approval of the Offering, the proposed acquisition will occur as anticipated, that the Company will raise sufficient funds, and that the Company will obtain all requisite approvals of the acquisition. These forward- looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important factors that may cause actual results to vary, include, without limitation, the risk that the proposed acquisitions may not occur as planned; the timing and receipt of requisite approvals and failure to raise sufficient funds under the Offering. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward- looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES INC. | HEMPCO FOOD AND FIBER INC. |
Aurelio Useche | Diane Jang |
President and CEO | CEO |
Relevium Technologies Inc.
+1.888.528.8687
investors@releviumcorp.com
www.releviumtechnologies.com
Hempco Food and Fiber Inc.
John Ross
Chief Financial Officer
+1.647.291.4234
john@hempcocanada.com
- Published in Relevium Technologies
Saskatchewan Joint Venture Project Update
Momentum Public Relations
Press Release: March 12 2018
Hillcrest Petroleum Ltd. (the ” Company ” or ” Hillcrest “) is pleased to announce that the Company has submitted the license documents to the Provincial Regulator that are required in order to commence the re-development of the West Hazel oil pool (“the Field”), located in Western Saskatchewan. Regulatory approval is expected before the end of April after which the Company will undertake field operations with the objective of restoring oil production from the Field to approximately 300 barrels of oil per day (“bopd”).
Further to previous announcements regarding Western Canada oil assets, the Company has executed an agreement where it, via a wholly owned subsidiary and as operator of record for the field, will earn up to a 75% Working Interest. Production restoration operations are expected to commence during the second quarter of this year. Hillcrest commissioned and received a 3 rd party technical report that identifies additional development opportunities within the Field. Both behind-pipe re-completions as well as in-fill drilling potential have been identified, and Hillcrest is planning to pursue production increases from within the Field during the 3 rd and 4 th quarters of 2018.
The primary terms of the agreement regarding the restoration of production of the Field are as follows:
- – The Company, as operator, will earn up to 75% Working Interest in the Field by contributing technical expertise and funding to restore production. Hillcrest’s Working Interest will revert to 50% once the Company has recovered all production restoration costs from the production revenues.- Hillcrest has arranged third party project funding which has been provided on a non-dilutive basis to Hillcrest shareholders. Project funding will be secured by the Assets and by the Company.
– Additional infield development opportunities, such as well re-completions or development drilling locations, are expected to be financed through cash flow from the assets.
“Hillcrest is very pleased that production restoration operations at the West Hazel field in Saskatchewan are imminent.” Don Currie, Hillcrest Petroleum CEO, states: “The project will provide near-term cash flow which may increase if and when we undertake further development operations. The Field was producing over 300 bopd when the former operators suspended production due to cyclically low oil prices. Hillcrest is confident production can be restored to previous levels after which further development will be considered. The Company has a majority working interest in the Field which was obtained at a very attractive cost level. Current commodity prices along with reduced operating expenses are expected to enhance the profitability of the Field. In addition to West Hazel, Hillcrest continues to review and pursue other Western Canada based opportunities and will inform our shareholders as material acquisitions or partnerships occur.,
For more information on Hillcrest Petroleum Ltd, contact Don Currie toll free at 1-855-609-0006 or visit the Company’s website at www.hillcrestpetroleum.com
ON BEHALF OF THE BOARD
Donald Currie
Chief Executive Officer and Director
Cautionary Statement Regarding “Forward-Looking” Information
Some of the statements contained in this news release are forward-looking statements and information within the meaning of applicable securities laws. Forward-looking statements and information can be identified by the use of words such as “expects”, “intends”, “is expected”, “potential”, “suggests” or variations of such words or phrases, or statements that certain actions, events or results “may”, “could”, “should”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements and information are not historical facts and are subject to a number of risks and uncertainties beyond the Company’s control. Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this news release. Accordingly, readers should not place undue reliance on forward-looking statements. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking statements, except as may be required by law.
Neither TSX Venture Exchange nor its Regulations Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
- Published in Hillcrest Petroleum